The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.
The Iowa State football program is replenishing the ranks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback